Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05723523 · ClinicalTrials.gov registry record · NA
A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 3,230
- Enrollment target
NCT05723523: Completed NA study, sponsored by HealthPartners Institute.
NCT05723523 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 3,230 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (130% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05723523, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,230 participants
- Enrollment target
Study Summary
Most experts advocate for early detection of cognitive impairment (CI) so that patients and caregivers can be prepared for making difficult decisions and to improve quality of life, but studies show that screening alone isn't sufficient to change clinician actions related to early detection. Using predictive modelling developed with machine learning methods and sophisticated clinical decision support (CDS) tools, it is possible to identify patients at elevated risk for CI and make it much easier for primary care to engage and support patients and caregivers in meaningful care planning. The goal of this study is to implement and evaluate a low-cost, highly scalable CI-CDS system integrated within the electronic health record that has high potential to improve early CI detection and care and translate massive public and private sector investments in health informatics into tangible health benefits for large numbers of people.
Primary Outcome
CI detection as indicated by EHR documentation of CI diagnosis up to 24 months after index visit.
Interventions
- OTHER CI-CDS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,230 participants |
| Start Date | 2023-08-23 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What the finished NCT05723523 record still lists
NCT05723523 is an interventional study that assigns participants to a tested intervention. Its 3,230 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (130% higher).
The record links to 0 conditions, and to 1 intervention - of which CI-CDS is the first listed.
NCT05723523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05723523 about?
NCT05723523 is a clinical study titled "A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment". Most experts advocate for early detection of cognitive impairment (CI) so that patients and caregivers can be prepared for making difficult decisions and to improve quality of life, but studies show that screening alone isn't sufficient to change clinician actions related to early detection. Using p...
What is the current status of trial NCT05723523?
This trial is currently completed. It is a NA study. The enrollment target is 3,230 participants. The study started on 2023-08-23. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT05723523?
The interventions under investigation include: CI-CDS (OTHER).
Who is sponsoring clinical trial NCT05723523?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05723523's enrollment target sits among peer trials
3,230 37th of 2000 higher than 1,964 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06587529 · 3,218 participants · NA
Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children
- NCT06953375 · 3,250 participants · NA
Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
- NCT06760507 · 3,209 participants · NA
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
- NCT02043457 · 3,200 participants
Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI